Immunovia publishes the annual report for the financial year 2020
LUND (SWEDEN) – Immunovia has today published the annual report for 2020. It is available on Immunovia’s website . “After many years of intensive preparation, Immunovia is close to a commercial breakthrough with the launch of our blood test for early detection of pancreatic cancer – IMMray™ PanCan-d – in the first quarter of 2021. Thus, Immunovia will be the first company in the world to launch a test that, by virtue of its early detection capabilities, can provide improved care and survival of pancreatic cancer patients”, said Patrik